Gross Profit: Revenues from operations less the associated costs.
Aprea Therapeutics, Inc. (APRE) had Gross Profit of $0.12M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.12M |
|
$-3.24M |
|
-- |
|
|
Gross Profit |
$0.12M |
$3.51M |
|
$-3.39M |
|
$0.15M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-3.24M |
|
$-3.39M |
|
$-3.38M |
|
6.08M |
|
6.08M |
|
$-0.53 |
|
$-0.53 |
|
| Balance Sheet Financials | |
$16.93M |
|
$0.07M |
|
$0.38M |
|
$17.31M |
|
$3.17M |
|
-- |
|
$0.73M |
|
$3.90M |
|
$13.41M |
|
$13.41M |
|
$13.41M |
|
5.75M |
|
| Cash Flow Statement Financials | |
$-6.76M |
|
$0.00M |
|
$0.44M |
|
$22.89M |
|
$16.57M |
|
$-6.32M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2868.30% |
|
-2868.30% |
|
-- |
|
-2742.23% |
|
-2742.22% |
|
$-6.76M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-24.14% |
|
-24.14% |
|
-18.71% |
|
-24.14% |
|
$2.33 |
|
$-1.11 |
|
$-1.11 |
|